Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/17/2002CA2053826C Pharmaceutical compositions active in the therapy of neurological affections in aids patients
12/17/2002CA2052745C Process for the preparation of carnosic acid and the use of the acid for its anticarcinogenic and antiviral properties
12/17/2002CA2037408C A nonaqueous pharmaceutical macrolide solution
12/14/2002CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/13/2002WO2001096575A1 Ceramide kinase and dna encoding the same
12/13/2002CA2412876A1 Ceramide kinase and dna encoding the same
12/12/2002WO2002099427A1 Srpks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099426A1 Pecis as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099140A1 GLRAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099138A2 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099125A1 PIBs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099123A1 Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder
12/12/2002WO2002099122A1 Modifiers of the p53 pathway and methods of use
12/12/2002WO2002099113A1 Macrolide compounds, antifungal agents using the same, macrolide compound-producing bacterium belonging to the genus sorangium and process for producing macrolide compounds using the same
12/12/2002WO2002099101A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002WO2002099099A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
12/12/2002WO2002099090A1 Bcl-2 dnazymes
12/12/2002WO2002099083A2 Gfats as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099075A2 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099074A2 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099065A2 Compositions and methods for preventing neural tube disorders
12/12/2002WO2002099060A2 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099059A2 U5-200KDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099058A2 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099057A2 Sams modifiers of the p53 pathway and methods of use
12/12/2002WO2002099056A2 C22c7orfs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099055A2 Cips as modifiers of the p53 pathway and method of use
12/12/2002WO2002099054A2 Hccss as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099053A2 Slc22as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099052A2 Opns as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099051A2 Nits as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099050A2 Tprs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099049A2 Tbc1d1s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099048A2 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099047A2 PROMLs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099046A2 Spo11 as modifier of the p53 pathway and methods of use
12/12/2002WO2002099044A2 B3galts as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099043A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002099042A2 Cads as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099041A2 Ces2s as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099040A2 Igs as modifiers of the p53 pathway and methods of use
12/12/2002WO2002099036A2 Inhibition of neurodegeneration
12/12/2002WO2002098916A2 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002WO2002098901A2 Peptide deformylase inhibitors
12/12/2002WO2002098899A2 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098898A2 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098890A2 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/12/2002WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002WO2002098883A1 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
12/12/2002WO2002098882A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
12/12/2002WO2002098881A1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative
12/12/2002WO2002098880A1 5-ethyl-imidazotriazinones
12/12/2002WO2002098879A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/12/2002WO2002098878A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/12/2002WO2002098877A1 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
12/12/2002WO2002098876A1 Cak inhibitors and uses thereof
12/12/2002WO2002098875A1 Carboline derivatives as pde-5 inhibitors
12/12/2002WO2002098874A2 Inhalation capsules
12/12/2002WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002WO2002098868A1 Epothilone derivatives
12/12/2002WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002WO2002098864A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
12/12/2002WO2002098860A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma
12/12/2002WO2002098857A1 New indole derivatives with 5-ht6 receptor affinity
12/12/2002WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002WO2002098853A2 Inhibitors of cell proliferation, angiogenesis, fertility, and muscle contraction
12/12/2002WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002WO2002098851A1 Derivatives 0f n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, method for producing salts and bases thereof, physiologically active n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, a pharmaceutical composition and curing method
12/12/2002WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002WO2002098847A1 Cycloalkenylsulfonamide derivatives
12/12/2002WO2002098846A1 Sulfonamide derivatives
12/12/2002WO2002098843A2 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
12/12/2002WO2002098515A2 Topical treatments using alkanolamines
12/12/2002WO2002098511A1 Compositions comprising oestrone-3-0-sulphamate and trail (tnf-related apoptosis inducing ligand)
12/12/2002WO2002098510A1 Combination of a ptpase inhibitor and an aldose reductase inhibitor
12/12/2002WO2002098501A2 Method and apparatus for treating tumors using low strength electric fields
12/12/2002WO2002098496A1 An aerosol forming device for use in inhalation therapy
12/12/2002WO2002098482A2 System for osmotic delivery of pharmaceutically active agents
12/12/2002WO2002098467A1 Slc2as as modifiers of the p53 pathway and methods of use
12/12/2002WO2002098462A1 Remedies containing aldose reductase inhibitor as the active ingredient for demyelinating diseases or diseases associated with demyelination
12/12/2002WO2002098461A2 Integrin linked kinase modulation of leukocyte trafficking
12/12/2002WO2002098459A2 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
12/12/2002WO2002098440A1 Drugs for diabetes
12/12/2002WO2002098439A1 Environmentally safe insect repellent composition
12/12/2002WO2002098437A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002WO2002098436A1 Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
12/12/2002WO2002098434A1 Method of producing calcium gluconolactate, compositions, processes and uses of same
12/12/2002WO2002098433A1 Drugs for intestinal diseases
12/12/2002WO2002098432A1 Methods of treating cardiac disorders
12/12/2002WO2002098431A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
12/12/2002WO2002098430A1 Antimycotic agent
12/12/2002WO2002098429A1 Ethanolamine, diethanolamine or triethanolamine salt of zopolrestat
12/12/2002WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002WO2002098427A2 Sustained-release analgesic compounds
12/12/2002WO2002098426A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
12/12/2002WO2002098425A1 Substituted 4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof
1 ... 5620 5621 5622 5623 5624 5625 5626 5627 5628 5629 5630 5631 5632 5633 5634 5635 5636 5637 5638 5639 5640 ... 7860